Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Isis Innovation's Rakesh Roshan investigates the looming age of quantum computing.
GUV's list of hot spin-outs to watch in 2015.
A review of our latest event, the GUV Summit 2014.
GUV's tech transfer regions feature arrives in the far east.